Theravance Biopharma to Present at Two Upcoming Investor Conferences
- 29th Annual
Piper Jaffray Healthcare Conferenceon Tuesday, November 28, 2017at 8:00 a.m. ET. The conference will be held November 28 - 29at the Lotte New York Palace Hotel. Evercore ISI Biopharma Catalyst/Deep Dive Conferenceon Wednesday, November 29, 2017at 8:45 am ET. The conference will be held November 29 - 30at the Boston Harbor Hotel.
A live broadcast of each event will be available by visiting the Investor Relations section of
Our pipeline of internally discovered product candidates includes potential best-in-class medicines to address the unmet needs of patients being treated for serious conditions primarily in the acute care setting. VIBATIV® (telavancin), our first commercial product, is a once-daily dual-mechanism antibiotic approved in the U.S.,
In addition, we have an economic interest in future payments that may be made by
For more information, please visit www.theravance.com.
THERAVANCE®, the Cross/Star logo, and VIBATIV® are registered trademarks of the
Head of Investor Relations
View original content with multimedia:http://www.prnewswire.com/news-releases/theravance-biopharma-to-present-at-two-upcoming-investor-conferences-300559660.html